GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
Stocks Most Shunned by Hedge Funds and Mutual Funds
SA Asks: Which Weight-loss Stocks Should Investors Be Watching?
Corbus Outlines Phase 1 Results From ADC Trial for Bladder, Cervical Cancers
FDA Oncology Chief Says International Clinical Trials Should Be Priority
'Stick With What's Working' as Markets Head Into June Trade: Fundstrat's Tom Lee
Here's How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 5 Years
Viking Therapeutics (NASDAQ:VKTX) has outperformed the market over the past 5 years by 37.13% on an annualized basis producing an average annual return of 50.59%. Currently, Viking Therapeutics has a